GlassScriptPhysician profile
Andrew Miller
NPI 1093244790
$3,072.51
in general payments reported to CMS, 2019-2025
24 companies · $665 in 2025
The $665 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $42.31 · 2022: $61.84 · 2023: $1,641 · 2024: $663 · 2025: $665.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,951 · Education: $17.19.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,951.17 |
| Education | $17.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mallinckrodt Hospital Products INC. | $488.13 | 2023-2025 | Acthar |
| Regeneron Healthcare Solutions, INC. | $333.63 | 2023-2025 | Eylea, Eylea Hd |
| Bausch & Lomb Americas INC. | $284.24 | 2023-2025 | Envista Envy, Xipere, Vyzulta |
| Apellis Pharmaceuticals, INC. | $278.37 | 2023-2025 | Syfovre |
| Oyster Point Pharma, INC. | $255.64 | 2023 | Tyrvaya |
| Abbvie INC. | $176.44 | 2023-2025 | |
| Horizon Therapeutics Plc | $154.37 | 2023 | Tepezza, Uplizna |
| Sun Pharmaceutical Industries INC. | $141.01 | 2022-2024 | Cequa |
| Amgen INC. | $123.18 | 2025 | Tepezza |
| Ani Pharmaceuticals, INC. | $109.24 | 2023-2025 | Purified Cortrophin Gel, Iluvien |
| Alcon Vision LLC | $108.95 | 2023-2025 | Rocklatan, Tryptyr, Clareon |
| New World Medical,INC. | $103.38 | 2023 | |
| Genentech USA, INC. | $98.63 | 2024-2025 | Vabysmo |
| Novartis Pharmaceuticals Corporation | $87.24 | 2023 | |
| Biotissue Holdings INC. | $52.62 | 2022-2023 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $42.31 | 2021 | |
| Merz Pharmaceuticals, LLC | $39.12 | 2023-2024 | Xeomin |
| Rayner Intraocular Lenses Limited | $37.91 | 2025 | Rayner Cataract Set 1, Rayone Emv, Rayone Aspheric |
| Thea Pharma INC. | $36.58 | 2023-2025 | Iyuzeh |
| Dompe US, INC. | $34.90 | 2022 | |
| Abiomed | $25.08 | 2024 | |
| Alimera Sciences, INC. | $23.20 | 2024 | Iluvien, Yutiq |
| Tarsus Pharmaceuticals, INC. | $21.10 | 2025 | Xdemvy |
| Coopervision INC. | $17.24 | 2023 | Biofinity Contact Lens |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Miller listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.